nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Sinus headache—Montelukast—chronic obstructive pulmonary disease	0.0562	0.0582	CcSEcCtD
Emedastine—Eye pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0395	0.0409	CcSEcCtD
Emedastine—Sensation of foreign body—Prednisolone—chronic obstructive pulmonary disease	0.0311	0.0322	CcSEcCtD
Emedastine—Conjunctival hyperaemia—Prednisolone—chronic obstructive pulmonary disease	0.023	0.0238	CcSEcCtD
Emedastine—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.0193	0.02	CcSEcCtD
Emedastine—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.0186	0.0192	CcSEcCtD
Emedastine—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.0172	0.0178	CcSEcCtD
Emedastine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.0162	0.0168	CcSEcCtD
Emedastine—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.0158	0.0163	CcSEcCtD
Emedastine—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.0156	0.0162	CcSEcCtD
Emedastine—Endophthalmitis—Prednisone—chronic obstructive pulmonary disease	0.0155	0.016	CcSEcCtD
Emedastine—Olanzapine—CYP1A2—chronic obstructive pulmonary disease	0.0138	0.413	CrCbGaD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.0136	0.0141	CcSEcCtD
Emedastine—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0136	0.014	CcSEcCtD
Emedastine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.0129	0.0133	CcSEcCtD
Emedastine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.0128	0.0132	CcSEcCtD
Emedastine—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.0125	0.0129	CcSEcCtD
Emedastine—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.0122	0.0126	CcSEcCtD
Emedastine—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.0119	0.0123	CcSEcCtD
Emedastine—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.0117	0.0121	CcSEcCtD
Emedastine—Olanzapine—HTR2A—chronic obstructive pulmonary disease	0.0117	0.349	CrCbGaD
Emedastine—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.0109	0.0113	CcSEcCtD
Emedastine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.0102	0.0105	CcSEcCtD
Emedastine—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00982	0.0102	CcSEcCtD
Emedastine—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00982	0.0102	CcSEcCtD
Emedastine—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00961	0.00995	CcSEcCtD
Emedastine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00955	0.00988	CcSEcCtD
Emedastine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00943	0.00976	CcSEcCtD
Emedastine—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00942	0.00974	CcSEcCtD
Emedastine—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00942	0.00974	CcSEcCtD
Emedastine—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00927	0.00959	CcSEcCtD
Emedastine—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00922	0.00954	CcSEcCtD
Emedastine—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00889	0.0092	CcSEcCtD
Emedastine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00872	0.00902	CcSEcCtD
Emedastine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00872	0.00902	CcSEcCtD
Emedastine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.0086	0.0089	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00857	0.00886	CcSEcCtD
Emedastine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00856	0.00885	CcSEcCtD
Emedastine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00854	0.00883	CcSEcCtD
Emedastine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00829	0.00858	CcSEcCtD
Emedastine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00828	0.00857	CcSEcCtD
Emedastine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00824	0.00852	CcSEcCtD
Emedastine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00823	0.00852	CcSEcCtD
Emedastine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00823	0.00851	CcSEcCtD
Emedastine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00823	0.00851	CcSEcCtD
Emedastine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00811	0.00839	CcSEcCtD
Emedastine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00807	0.00835	CcSEcCtD
Emedastine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00806	0.00834	CcSEcCtD
Emedastine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00803	0.00831	CcSEcCtD
Emedastine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00801	0.00828	CcSEcCtD
Emedastine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00801	0.00828	CcSEcCtD
Emedastine—Olanzapine—ALB—chronic obstructive pulmonary disease	0.00797	0.239	CrCbGaD
Emedastine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00777	0.00804	CcSEcCtD
Emedastine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00756	0.00782	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00691	0.00715	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00691	0.00715	CcSEcCtD
Emedastine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00688	0.00712	CcSEcCtD
Emedastine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00688	0.00712	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00677	0.00701	CcSEcCtD
Emedastine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00654	0.00677	CcSEcCtD
Emedastine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00654	0.00677	CcSEcCtD
Emedastine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00651	0.00674	CcSEcCtD
Emedastine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00651	0.00674	CcSEcCtD
Emedastine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00649	0.00672	CcSEcCtD
Emedastine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00648	0.00671	CcSEcCtD
Emedastine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00648	0.00671	CcSEcCtD
Emedastine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00641	0.00663	CcSEcCtD
Emedastine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00635	0.00657	CcSEcCtD
Emedastine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0062	0.00642	CcSEcCtD
Emedastine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00618	0.00639	CcSEcCtD
Emedastine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00615	0.00636	CcSEcCtD
Emedastine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00612	0.00633	CcSEcCtD
Emedastine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00585	0.00605	CcSEcCtD
Emedastine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00571	0.0059	CcSEcCtD
Emedastine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00571	0.0059	CcSEcCtD
Emedastine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00559	0.00578	CcSEcCtD
Emedastine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00553	0.00572	CcSEcCtD
Emedastine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00552	0.00571	CcSEcCtD
Emedastine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00549	0.00568	CcSEcCtD
Emedastine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00539	0.00557	CcSEcCtD
Emedastine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00521	0.00539	CcSEcCtD
Emedastine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00521	0.00539	CcSEcCtD
Emedastine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00518	0.00536	CcSEcCtD
Emedastine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00479	0.00495	CcSEcCtD
Emedastine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00479	0.00495	CcSEcCtD
Emedastine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00472	0.00488	CcSEcCtD
Emedastine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00472	0.00488	CcSEcCtD
Emedastine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00469	0.00485	CcSEcCtD
Emedastine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00462	0.00478	CcSEcCtD
Emedastine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00452	0.00468	CcSEcCtD
Emedastine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00446	0.00461	CcSEcCtD
Emedastine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00421	0.00435	CcSEcCtD
Emedastine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00421	0.00435	CcSEcCtD
Emedastine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.0042	0.00435	CcSEcCtD
Emedastine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.0042	0.00435	CcSEcCtD
Emedastine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00418	0.00432	CcSEcCtD
Emedastine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00418	0.00432	CcSEcCtD
Emedastine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.00432	CcSEcCtD
Emedastine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00412	0.00426	CcSEcCtD
Emedastine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00412	0.00426	CcSEcCtD
Emedastine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00409	0.00424	CcSEcCtD
Emedastine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00397	0.00411	CcSEcCtD
Emedastine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00397	0.00411	CcSEcCtD
Emedastine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00395	0.00408	CcSEcCtD
Emedastine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00372	0.00385	CcSEcCtD
Emedastine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00353	0.00365	CcSEcCtD
Emedastine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00345	0.00357	CcSEcCtD
Emedastine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00324	0.00335	CcSEcCtD
Emedastine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00309	0.0032	CcSEcCtD
Emedastine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00303	0.00314	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00272	0.00281	CcSEcCtD
Emedastine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00271	0.0028	CcSEcCtD
Emedastine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00258	0.00266	CcSEcCtD
Emedastine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00256	0.00265	CcSEcCtD
Emedastine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00255	0.00264	CcSEcCtD
Emedastine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00228	0.00236	CcSEcCtD
Emedastine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00228	0.00236	CcSEcCtD
Emedastine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00226	0.00234	CcSEcCtD
Emedastine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00188	0.00195	CcSEcCtD
Emedastine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00186	0.00192	CcSEcCtD
Emedastine—Rash—Prednisone—chronic obstructive pulmonary disease	0.00166	0.00171	CcSEcCtD
Emedastine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00165	0.00171	CcSEcCtD
Emedastine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00165	0.0017	CcSEcCtD
